logo
Experts fear extinction as California's monarch population plummets

Experts fear extinction as California's monarch population plummets

Yahoo17-02-2025
The Western population of the monarch butterfly has declined to a near-record low with fewer than 10,000 found living in the US state of California this winter, a foreboding sign for the future of the beloved black-and-orange insect.
An annual count recorded 9,119 butterflies this winter, according to results released by the Xerces Society for Invertebrate Conservation. This is the second-lowest population recorded since tracking began in 1997. An all-time low of fewer than 2,000 monarchs was recorded in 2020.
The society said these numbers underscored the importance of the US Fish and Wildlife Service's new proposal to list the butterfly as a federally endangered species.
The butterfly's Western population has plummeted more than 95% since the 1980s, when up to 4 million butterflies were estimated to spend winter in California, according to the California Department of Fish and Wildlife.
Without urgent conservation efforts, the US Fish and Wildlife Service estimates that the Western population faces a 99% chance of extinction by 2080.
Habitat destruction, pesticides and extreme weather fluctuation due to climate change are all to blame for the butterfly's decline.
This year's particularly poor showing can also be attributed to an usually hot and dry fall, which probably slowed butterfly breeding and the metamorphosis of caterpillars into butterflies, said Emma Pelton, an endangered species biologist with the Xerces Society.
Los Angeles-area wildfires wiped out habitats
At a local level, the recent Los Angeles-area wildfires damaged tree groves where these butterflies live, including a habitat site in Lower Topanga Canyon where more than 100 butterflies were recorded in last year's count, she said.
Another alarming finding was made at a site in Santa Barbara County, which went from recording 33,200 monarchs last winter to only 198 this year.
The count is conducted by about 400 volunteers at 257 sites along California's coastline and Baja California, Mexico, where the Western monarch population gathers to pass winter before fanning out across the West from Arizona to Idaho in spring.
The Eastern monarch population — which has decreased more than 80% since the 1980s — spends winters in the mountains of central Mexico and warm months in the eastern half of the United States, according to the US Fish and Wildlife Service.
This year's Western monarch count marks a sharp decline from the last three years, when more than 200,000 Western monarchs were recorded each year, thanks, in part, to more favourable weather conditions, said Pelton.
But even counts in the 200,000 range mark a dangerous decrease from the millions of butterflies observed in the 1980s that scientists consider a stable population level.
"Insect populations commonly fluctuate from year to year," according to the California Department of Fish and Wildlife. "The overall downward trend remains concerning, particularly if the threats are not ameliorated."
Calls to list monarch as endangered species since 2014
The monarch butterfly was first petitioned to be listed under the federal Endangered Species Act in 2014, but that effort was shelved due to more urgent population priorities.
In late 2024, the US Fish and Wildlife Service released a proposal to list the butterfly as an endangered species.
"The iconic monarch butterfly is cherished across North America, captivating children and adults throughout its fascinating lifecycle. Despite its fragility, it is remarkably resilient, like many things in nature when we just give them a chance," said Martha Williams, then-director of the Fish and Wildlife Service, in a December statement.
"Science shows that the monarch needs that chance."
The service has also proposed designating 4,395 acres as critical habitat for the Western monarch population across Alameda, Marin, Monterey, San Luis Obispo, Santa Barbara, Santa Cruz and Ventura counties to help support population regrowth.
The service will be accepting public comments on the proposed threatened species designation and make a final decision by the end of 2025.
More pesticide regulation needed to save monarch
In addition to supporting the designation, the Xerces Society is urging the US Environmental Protection Agency (EPA) to take into account the effect of pesticides on butterflies before approving the products for market.
Currently, the only insect included in the EPA's required pesticide testing is the adult honeybee.
Testing by the Xerces Society and the University of Nevada-Reno found that milkweed leaves, the main food source for the monarch caterpillar, were contaminated by 64 pesticides. One of these pesticides, methoxyfenozide, was found in 96% of milkweed samples, but it is allowed to be used under current pesticide regulations because it is not toxic to bees.
"We know pesticides are a key driver of monarch and other pollinator declines. Yet there are glaring gaps in the EPA's oversight of pesticides: the vast majority of pesticides have never been tested for their impacts on butterflies," said Rosemary Malfi, director of conservation policy at the Xerces Society, in a statement.
"How can we protect these essential species if we're missing the basic information needed to make better decisions?"
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Researchers develop floating solar panels that could dramatically reshape eastern US: 'Doesn't sound like a lot, but it is'
Researchers develop floating solar panels that could dramatically reshape eastern US: 'Doesn't sound like a lot, but it is'

Yahoo

timea day ago

  • Yahoo

Researchers develop floating solar panels that could dramatically reshape eastern US: 'Doesn't sound like a lot, but it is'

Researchers develop floating solar panels that could dramatically reshape eastern US: 'Doesn't sound like a lot, but it is' Floating solar panels placed on bodies of water can actually produce more power per square foot than land-based systems. But scientists still have a lot to learn about how this tech affects nature and nearby communities. A study reported by the Cornell Chronicle, published on June 13 in the Cell Reports Sustainability journal, looked at both the benefits and the possible downsides of using floating solar across the U.S. Northeast. The researchers started by figuring out how many waterbodies could realistically support floating solar panels. They found that about 3.5% of existing bodies of water in the region would work. If all of them were used, floating solar could supply 25% of the Northeast's solar energy needs by 2050. That would also make up for all of the land area normally needed for land-based solar. The researchers said floating solar could provide 5% of the region's solar needs while avoiding placing panels in spots important for biodiversity and recreation. Combined with existing solar installations on land, the region's solar production could improve by 194%. "Five percent doesn't sound like a lot, but it is," said senior author Steven Grodsky. "That's 5% less that you would need to generate with terrestrial solar, which equates to thousands of acres and a major boost to solar energy generation with low potential for conflict." In New York State, floating solar could contribute 55% of the state's energy needs by 2030. If areas important to biodiversity are left out, that number drops to 24%. The study also points to a possible trade-off. Grodsky's team found that floating solar increased the amount of planet-warming gases by almost 27% on small ponds. He said, "Freshwater is far rarer than land, and we may wish to consider socioecological impacts of floating photovoltaics concurrent with potential co-benefits like land sparing." Lead author Adam Gallaher said this research gives communities and decision-makers a better way to plan: "This gives policymakers and stakeholders a playbook to take a data-driven, fact-based approach to tackling multiple crises." Do you think we should place solar panels over bodies of water? Absolutely Depends on the place Depends on the cost No way Click your choice to see results and speak your mind. Floating solar means towns and energy providers will have to pay less for land and extra equipment. That can free up money for other local needs like schools and repairs. Plus, these savings can help keep energy prices stable for residents. For individuals wanting to make a difference on their own, installing solar panels is the ultimate home energy hack, because it can bring your cost of energy down to or near $0. EnergySage provides a free service that makes it easy to compare quotes from vetted local installers and potentially save up to $10,000 on solar installations. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the the daily Crossword

The Naked Gun Spoofs ‘Genius Who's Gonna Save The World With His Electric Cars'. Whoever That Is
The Naked Gun Spoofs ‘Genius Who's Gonna Save The World With His Electric Cars'. Whoever That Is

Forbes

time2 days ago

  • Forbes

The Naked Gun Spoofs ‘Genius Who's Gonna Save The World With His Electric Cars'. Whoever That Is

The reviews are in for the cop parody legacyquel The Naked Gun, and they're overwhelmingly positive. The movie is 'extremely funny,' reckons The Guardian. It's a film that 'has a better chance of producing a belly laugh than any in recent memory,' suggests Empire. 'The Naked Gun's joke-per-minute ratio is truly astounding,' reports Collider. The Naked Gun, starting its theater run August 1, has a 91% critic score on Rotten Tomatoes, from 170 reviews. So, sure, get to this slapstick flick if you want to laugh your socks off, but there's another reason to go see it: there's tech. Lots of tech. Green tech. The film's villain is a megalomaniac billionaire CEO of an electric car company. An electric car company with driverless cars. An electric car company with driverless cars that crash in mysterious circumstances. But the movie's evil billionaire isn't Elon Musk, it's Richard Kane (Danny Huston), a genius interested in men's sperm count and who's 'gonna save the world with his electric cars.' No, definitely nothing like Elon Musk. And while there's a spacesuit in the movie, and a humanoid robot—no doubt remote controlled by a human operator—there are no satellite dishes, brain implants, or tarnished social media sites. There are, however, plenty of fart jokes. Again, nothing at all like Elon Musk. The Naked Gun series dates back to the 1982 cop parody show Police Squad! by Jim Abrahams and brothers David and Jerry Zucker, collectively known as ZAZ. This was followed by three ZAZ-produced Naked Gun movies from the late 1980s through to the mid-1990s. In film number four—a non-ZAZ production—gravel-voiced Liam Neeson plays Frank Drebin Jr., the son of the original's deadpanning Lt. Frank Drebin (Leslie Nielsen). He teams up with femme fatale Beth Davenport (Pamela Anderson) in a laugh-a-minute spectacle of slapstick, sight gags, and wordplay. The Oscar-nominated star of Schindler's List is subjected to visual sexual innuendo in Austin Powers-like silhouette gags that are knockout funny. There's also a series of running gags that get funnier and funnier. The movie's apocalyptic plot hinges on a digital doohickey identified onscreen as the P.L.O.T. Device and operated by (it's-not-Musk-remember) Kane, who wants to reset a world he considers to be ruined: let the world's population fight themselves to oblivion, then build back better with a chosen few. Before the gizmo gets activated, Kane gifts the Police Squad with a driverless electric cop car (it's not a Tesla, in reality it's a disguised Hyundai Ioniq 6). Earlier, Drebin Jr. had grumbled 'I remember when the only things that were electric were eels, chairs, and Catherine Zeta-Jones in Chicago.' Evil genius Kane founded car maker Edentech 'to save the world' and has 'created technologies to rival the gods.' Not at all like Musk's claims that Tesla will become the world's leading robotics company, ushering in the 'closest thing to heaven we can get on Earth.' The Naked Gun pokes fun at driverless cars, but not EVs in general. Drebin Jr. hits a cyclist when driving his ICE car, and he does so again when sitting in the driverless cop car. The movie's a hoot. CREDITSDistribution: ParamountProduction company: Fuzzy DoorCast: Liam Neeson, Pamela Anderson, Paul Walter Hauser, CCH Pounder, Kevin Durand, Cody Rhodes, Liza Koshy, Eddie Yu, Danny HustonDirector: Akiva SchafferScreenwriters: Dan Gregor, Doug Maud, Akiva SchafferProducers: Seth MacFarlane, Erica HugginsExecutive producers: Daniel M. Stillman, Akiva Schaffer, Pete Chiappetta, Anthony Tittanegro, Andrew LaryDirector of photography: Brandon TrostProduction designer: Bill BrzeskiCostume designer: Betsy HeimannMusic: Lorne BalfeEditor: Brian Scott OldsVisual effects supervisor: Ashley BettiniRated PG-13. Runtime: 1 hour 25 minutes

These Two Simple Interventions May Cut CRC Recurrence Risk
These Two Simple Interventions May Cut CRC Recurrence Risk

Medscape

time2 days ago

  • Medscape

These Two Simple Interventions May Cut CRC Recurrence Risk

This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School and Old Dominion University in Norfolk, Virginia. New guidelines have lowered the age to begin screening for colon cancer to 45 years old. Although this change is positive, we're still seeing advanced cancer in younger patients who haven't been screened in time. Once diagnosed, these patients undergo surgery and chemotherapy and often return to us asking, 'What can I do now to help myself?' Two recent studies highlight interventions that are simple, affordable, and actionable today: exercise and aspirin. Let's take a closer look at the results. Exercise's Risk Reduction Potential The idea that exercise reduces cancer recurrence and mortality is supported by observational data. The mechanistic effects behind this have been ascribed to metabolic growth factors, inflammatory changes, immune function changes, and perhaps even positive impact on sleep. A study just published in The New England Journal of Medicine examined structured exercise after adjuvant chemotherapy for colon cancer. The phase 3 randomized CHALLENGE trial, mostly conducted at Canadian and Australian centers, recruited patients with resected stage II or III colon cancer (9.8% and 90.2%, respectively) who had completed adjuvant chemotherapy. Patients with recurrences within a year of diagnosis were excluded, as they were more likely to have highly aggressive, biologically active disease. Patients were randomized to receive healthcare education materials alone or in conjunction with a structured exercise program over a 3-year follow-up period. The exercise intervention, delivered in person or virtually, focused on increasing recreational aerobic activity over baseline by at least 10 metabolic equivalent task (MET). An increment of 10 MET hours per week is not too vigorous. It is essentially the equivalent of adding about 45-60 minutes of brisk walking or 25-30 minutes of jogging 3-4 times a week. Patients were asked to increase MET over the first 6 months and then maintain or further increase the amount over the next 2.5 years. They were permitted to structure their own exercise program by choosing the type, frequency, intensity, and duration of aerobic exercise. The primary endpoint was disease-free survival, with secondary endpoints assessing overall survival, patient-reported outcomes, and other outcomes. Although designed to detect differences at 3 years, follow-up was also performed out to 5 and 8 years. At a median follow-up of 7.9 years, exercise reduced the relative risk of disease recurrence, new primary cancer, or death by 28% ( P =.02). This benefit persisted — and even strengthened — over time, with disease-free survival increasing by 6.4 and 7.1 percentage points at 5 and 8 years, respectively. Musculoskeletal adverse events were slightly higher in the exercise group compared with the health education group (18.5% vs 11.5%, respectively), but only 10% were directly attributed to the exercise. There are considerations when interpreting these results. First, there was an attrition over time for compliance and training. It would be interesting to see whether that impacted the results. Second, it's unclear whether patient pedigree or a genomic pathway may predispose to a benefit here for the exercise group. But overall, this phase 3 trial provides class 1 evidence supporting exercise as a low-cost, high-impact intervention to reduce cancer recurrence. Adjuvant Aspirin in Colon Cancer Subset That's a perfect segue into another recent study looking at the effects of adjuvant aspirin on the prevention of recurrence. The ALASCCA trial— conducted across centers in Sweden, Denmark, Finland, and Norway — assessed patients with stage I-III rectal cancer or stage II-III colon cancer. It focused on a subset of patients with an oncogenic abnormality called PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha). PIK3CA occurs in approximately a third of colon cancers and is associated with significant chemotherapy resistance and a higher rate of disease progression. Of the included patients, 1103 (37%) had alterations in the PIK3CA pathway. Researchers randomized patients to receive either 160 mg of aspirin or placebo daily for 3 years, starting within 3 months of surgery. Among patients with PIK3CA mutations, aspirin dramatically reduced the risk for time to recurrence by nearly 50% at 3 years ( P =.044). Adverse events associated with aspirin were minimal, including one case each of gastrointestinal bleeding, hematoma, and allergic reaction. There is no evidence that higher aspirin doses provide greater prevention of colorectal cancer recurrence. The 160 mg use in the current study is fairly normal, roughly equivalent to two low-dose (81 mg) aspirin tablets. Now, it's worth noting that the use of aspirin for the primary prevention of cardiovascular disease was initially recommended by the US Preventive Task Services Force in 2016. This recommendation was then recanted in 2022, when the same group reported limited net benefit to this approach. Two Proactive Actions These studies highlight two interventions — exercise and aspirin — that are low cost, accessible, and appeal to patients eager to help prevent their cancer from recurring. Exercise is broadly beneficial and can be recommended immediately. For aspirin, patients should work with their oncologist to determine their PIK3CA mutation status, as this subgroup appears to benefit the most. These findings offer patients meaningful, proactive interventions they can apply to support their recovery and reduce the risk of recurrence. Hopefully these new findings will help guide your clinical conversations. I'm Dr David Johnson. Thanks for listening.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store